The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers
Abstract
OBJECTIVES: Levetiracetam is a broad-spectrum antiepileptic drug (AED) which is currently licensed in the United States and the United Kingdom and Ireland for use as adjunctive treatment of focal-onset seizures and myoclonic seizures or generalized tonic-clonic seizures, occurring as part of generalized epilepsy syndromes. In the United Kingdom and Ireland, it is also licensed as monotherapy treatment for focal-onset seizures. Previous small studies have suggested a low risk for major congenital malformations (MCM) with levetiracetam use in pregnancy. METHODS: The UK and Ireland Epilepsy and Pregnancy Registers are prospective, observational registration and follow-up studies that were set up to determine the relative safety of all AEDs taken in pregnancy. Here we report our combined results for first-trimester exposures to levetiracetam from October 2000 to August 2011. RESULTS: Outcome data were available for 671 pregnancies. Of these, 304 had been exposed to levetiracetam in monotherapy, and 367 had been exposed to levetiracetam in combination with at least one other AED. There were 2 MCM in the monotherapy group (0.70%; 95% confidence interval [CI] 0.19%-2.51%) and 19 in the polytherapy group 5.56% (3.54%–8.56%) [corrected]. The MCM rate in the polytherapy group varied by AED regimen, with lower rates when levetiracetam was given with lamotrigine (1.77%; 95% CI 0.49%-6.22%) than when given with valproate (6.90%; 95% CI 1.91%-21.96%) or carbamazepine (9.38%; 95% CI 4.37%-18.98%). CONCLUSION: This study, in a meaningful number of exposed pregnancies, confirms a low risk for MCM with levetiracetam monotherapy use in pregnancy. MCM risk is higher when levetiracetam is taken as part of a polytherapy regimen, although further work is required to determine the risks of particular combinations. With respect to MCM, levetiracetam taken in monotherapy can be considered a safer alternative to valproate for women with epilepsy of childbearing age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Child development following in utero exposure: Levetiracetam vs sodium valproate
Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088297 · Cited by 161
Self-citation
Cited by
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Perucca, E., Sabers, A., Thomas, S. V., Vajda, F., Faravelli, F., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30107-8 · Cited by 544
Self-citationMonotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., Hounsome, J., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010224.pub2 · Cited by 347
Manford, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8394-2 · Cited by 299
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236.pub2 · Cited by 277
Valproate in the treatment of epilepsy in girls and women of childbearing potential
Tomson, T., Marson, A., Boon, P., Canevini, M. P., Covanis, A., Gaily, E., Kälviäinen, R., & Trinka, E. (2015) · Epilepsia · doi:10.1111/epi.13021 · Cited by 267
Metadata
- Authors
- Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., & Hunt, S. J.
- Venue
- Neurology
- Published
- 2013-01-22
- Volume
- 80
- Issue
- 4
- Pages
- 400-405
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2006817220
- Cited by
- 165
- References
- 1
- FWCI
- 22.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers. https://app.cochat.ai/papers/10.1212/wnl.0b013e31827f0874
- The paper
- Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., & Hunt, S. J. (2013). Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers. Neurology. https://doi.org/10.1212/wnl.0b013e31827f0874
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.